R. Young, Angiosarcoma Lancet Oncol 11 983?91 DOI: 10, p.20537949, 2010.

M. Agulnik, An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas, Annals of Oncology, vol.24, issue.1, pp.257-63, 2013.
DOI : 10.1093/annonc/mds237

N. André, Has the time come for metronomics in low-income and middle-income countries?, The Lancet Oncology, vol.14, issue.6, pp.239-287, 2013.
DOI : 10.1016/S1470-2045(13)70056-1

Y. Sumikawa, Long-term metronomic docetaxel chemotherapy for inoperative angiosarcoma of the scalp, The Journal of Dermatology, vol.143, issue.4, pp.393-398, 2011.
DOI : 10.1111/j.1346-8138.2010.00988.x

H. Kopp, L. Kanz, and J. Hartmann, Complete remission of relapsing high-grade angiosarcoma with single-agent metronomic trofosfamide, Anti-Cancer Drugs, vol.17, issue.8, pp.997-1005, 2006.
DOI : 10.1097/01.cad.0000224453.39200.d7

T. Vogt, Antiangiogenetic therapy with pioglitazone, rofecoxib, and metronomic trofosfamide in patients with advanced malignant vascular tumors Cancer 98, p.14601096, 2003.

O. Mir, Feasibility of metronomic oral cyclophosphamide plus prednisolone in elderly patients with inoperable or metastatic soft tissue sarcoma, European Journal of Cancer, vol.47, issue.4, pp.515-524, 2011.
DOI : 10.1016/j.ejca.2010.11.025

N. André, M. Carré, and E. Pasquier, Metronomics: towards personalized chemotherapy?, Nature Reviews Clinical Oncology, vol.41, issue.7, pp.413-31499, 2014.
DOI : 10.1016/j.ejca.2012.11.029

J. Tang, 2013) ?-Adrenergic system, a backstage manipulator regulating tumour progression and drug target in cancer, therapy Semin Cancer Biol, vol.23, issue.6, p.24012659

J. Stiles, Targeting of beta adrenergic receptors results in therapeutic efficacy against models of hemangioendothelioma and angiosarcoma PLoS One 8 e60021 DOI: 10, p.3610939, 2013.

K. Chisholm, ??-Adrenergic receptor expression in vascular tumors, Modern Pathology, vol.13, issue.11, pp.1446-51
DOI : 10.1016/S1470-2045(11)70318-7

E. Pasquier, ??-blockers increase response to chemotherapy via direct antitumour and anti-angiogenic mechanisms in neuroblastoma, British Journal of Cancer, vol.15, issue.12, pp.2485-94
DOI : 10.1056/NEJMoa0911123

E. Pasquier, Propranolol potentiates the anti-angiogenic effects and anti-tumor efficacy of chemotherapy agents: implication in breast cancer treatment, Oncotarget, vol.2, issue.10, pp.797-809, 2011.
DOI : 10.18632/oncotarget.343